GPT and Hepatic fibrosis: Therefore, this study is aimed at developing a noninvasive approach by including LSM and routinely available noninvasive parameters in the analysis for the evaluation of liver fibrosis in HBeAg-positive patients with ALT of <2× ULN based on the fibrosis staging by liver biopsy.